BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Earnings History & Surprises

NASDAQ:BBOT • US1079241022

10.42 USD
+0.53 (+5.36%)
At close: Mar 6, 2026
10.46 USD
+0.04 (+0.38%)
After Hours: 3/6/2026, 8:02:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMay 7, 2026
PeriodQ4 / 2025
EPS Estimate-$0.53
Revenue Estimate

Last Reported

Most Recent
Release DateMar 3, 2026
PeriodQ3 / 2025
EPS Reported-$1.03
EPS Surprise -159.04%
Revenue Surprise %

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 -1.03 -0.40 -159.04% - - -
Q2 2025 - - - -
Q1 2025 - - - -
Q4 2024 - - - -
Q3 2024 - - - -
Q2 2024 - - - -
Q1 2024 - - - -
Q4 2023 - - - -
Q3 2023 - - - -
Q4 2022 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

BBOT EPS Q2Q GrowthBBOT EPS Q2Q GrowthEPS Q2Q Growth Q3/26 Q4/26 Q1/27 Q2/27 Q3/27 Q4/27 0 10 -10 20 30 40

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Related analysis

BBOT Overview BBOT Technical Analysis Report BBOT Fundamental Analysis Report BBOT Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

BRIDGEBIO ONCOLOGY THERAPEUT / BBOT Earnings FAQ

What is the most recent earnings date for BBOT stock?

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) last reported earnings on 3/3/2026.


Did BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) beat earnings estimates last quarter?

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) missed EPS estimates and missed revenue estimates in the most recent quarter.